Study of the Cabochon System for Improvement in the Appearance of Cellulite

Inclusion Criteria: * Female, age 18-55 * moderate or severe cellulite * BMI less than 35 * will not to try any other cellulite treatments through 12M follow-up Exclusion Criteria: * cellulite treatment on the thighs or buttocks in the last 90 days * prior liposuction in the thighs or buttocks * Greater than 10% increase or decrease in body weight within past 6 months * evidence of active infection or a fever \>38C * current or recent smoker * history of hypertension, diabetes or hypoglycemia * history of coagulopathy(ies) and/or on anticoagulant medication * history of cardiopathy or pneumopathy * history of severe anemia * has atrophic scars, or has a history of atrophic scars or keloids * taken within 14 days of treatment: * NSAIDs (e.g. aspirin, ibuprofen, naproxen) * Vitamin E, dietary supplements (e.g. Gingko Biloba, willow bark) * Herbal Teas * Subject is pregnant or lactating For Extended Follow-Up the following apply: Inclusion Criteria: * Subject was enrolled and treated in the CP-01-1004 study - Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite * Subject understands and accepts the obligation not to try or receive any other cellulite treatments through 3 year follow-up Exclusion Criteria: * Subject has undergone an injected drug, energy-based device, minimally-invasive or invasive procedure for contouring or cellulite on the buttocks or thighs since their 12 month study follow-up visit. * Subject has used skin care products (e.g. creams) for improvement in cellulite within 1 month prior to the follow-up visit.